halobetasol: Clinical Trials

7 trials of halobetasol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 terminated, 1 withdrawn. 7 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 27Completed 5, Terminated 1, Withdrawn 1
Phase 31Completed 1

Follow halobetasol: new trials by email Literature Review of halobetasol trials Research Report on halobetasol

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of CITI-002 in Adult Patients With Moderate Grade Hemorrhoids
Monad 1, Monad 2, Monad 3 - Hemorrhoids
Phase 2CompletedCitius Pharmaceuticals, Inc.3042022-04-222023-08-31
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
Treatment with Halobetasol propionate 0.05% topical spray - Atopic Dermatitis
Phase 2TerminatedSun Pharmaceutical Industries Limited202017-07-242019-09-25
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Plaque Psoriasis
Halobetasol Propionate - Plaque Psoriasis
Phase 2WithdrawnSun Pharmaceutical Industries Limited2017-01-012021-06-14
Safety and Efficacy of IDP-122 Lotion When Applied Topically to Subjects With Moderate to Severe Plaque Psoriasis
IDP-122 Vehicle Lotion, IDP-122 Vehicle Cream, IDP-122 Lotion - Psoriasis
Phase 2CompletedBausch Health Americas, Inc.1502016-06-012020-08-27
Safety and Efficacy of IDP-118 Lotion to Ultravate® in the Treatment of Plaque Psoriasis
IDP-118 Vehicle Lotion, IDP-118 Vehicle Cream, IDP-118 Lotion - Psoriasis
Phase 2CompletedBausch Health Americas, Inc.1542016-04-012020-08-20
Blinded Study of Topical Investigational Lotion Vs. Approved Cream in Treatment of Plaque Psoriasis
Halobetasol Proprionate Lotion 0.05%, Halobetasol Proprionate Cream 0.05% - Plaque Psoriasis
Phase 2CompletedTherapeutics, Inc.432010-07-012016-05-16
Effectiveness and Safety of Topical Halobetasol Propionate in the Treatment of Patients With Psoriasis
halobetasol, clobetasol - Psoriasis
Phase 2 / Phase 3CompletedAzidus Brasil1402008-07-012010-09-02

Conditions studied

Psoriasis (3)  ·  Dermatitis, Atopic (1)  ·  Hemorrhoids (1)

Sponsors

Bausch Health Americas, Inc. (2)  ·  Sun Pharmaceutical Industries Limited (2)  ·  Azidus Brasil (1)  ·  Citius Pharmaceuticals, Inc. (1)  ·  Therapeutics, Inc. (1)

Countries

United States (5)  ·  Brazil (1)

Top investigators

Binu J Alexander, MD (2)  ·  Alan Lader, PhD (1)  ·  Binu Alexander (1)  ·  Rajinder K Jalali, MD (1)

Results publications

PMID 30207807